Comment by
palinc2000 on Apr 13, 2023 8:34am
I suggest you read the compensation related info during Happy Hour ...... snd make it a double!!!
Comment by
palinc2000 on Apr 13, 2023 9:57am
I know the CEO is in a difficult position caused by many factors some of which may not be his fault but for Ch+**st sake just basic human decency would have dictated at minimum a FREEZE in compensation for management and Board Members and a decrease in the number of Directors . Show some compassion not your personal greed
Comment by
palinc2000 on Apr 13, 2023 10:42am
The apparent stable G&A expense in Q 1 was from the cancellation of activities in Europe according to what Dubuc said during the CC part of which was offet with increses in this side of the pond
Comment by
palinc2000 on Apr 13, 2023 11:53am
Imo there is NO WAY they can predict the outcome of the Phase 1 b clinical trial at this time .... Pharmas would be lining up to make a bid if predicting the outcome was possible . Being hopeful is not enough to reward mgmt before the fact
Comment by
palinc2000 on Apr 13, 2023 3:46pm
The more they believe in successful outcome in Th 1902 the more restraint they should show until that proves to be true.... especially in light of the extremely tight cash situation ,going concern note,Nasdaq delisting notice etc etc If Th 1902 turns out to be successful they will all be very rich ....and they know it ..... So I dont share your thoughts on this
Comment by
palinc2000 on Apr 13, 2023 5:14pm
I dont understand your purpose in your continued posting....If in fact you have moved on then move on....
Comment by
muslix1 on Apr 14, 2023 10:22am
what the f..k today up 10%..no news..
Comment by
Joemare on Apr 13, 2023 3:51pm
The board is clueless. What does Molson know on Phase I cancer research? Clueless executives. Clueless board. Blind leading the blind.
Comment by
Joemare on Apr 13, 2023 9:18am
A DISCUST. Can you post on LinkedIn - just the table that summarizes their bonus and payouts, as well as board members. Shameful. Shameful. Nothing to shareholders.